» Articles » PMID: 38444022

Cayratia Albifolia C.L.Li Exerts Anti-rheumatoid Arthritis Effect by Inhibiting Macrophage Activation and Neutrophil Extracellular Traps (NETs)

Overview
Journal Chin Med
Publisher Biomed Central
Date 2024 Mar 5
PMID 38444022
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cayratia albifolia C.L.Li (CAC), commonly known as "Jiao-Mei-Gu" in China, has been extensively utilized by the Dong minority for several millennia to effectively alleviate symptoms associated with autoimmune diseases. CAC extract is believed to possess significant anti-inflammatory properties within the context of Dong medicine. However, an in-depth understanding of the specific pharmaceutical effects and underlying mechanisms through which CAC extract acts against rheumatoid arthritis (RA) has yet to be established.

Methods: Twenty-four Sprague-Dawley rats were divided into four groups, with six rats in each group. To induce the collagen-induced arthritis (CIA) model, the rats underwent a process of double immunization with collagen and adjuvant. CAC extract (100 mg/kg) was orally administered to rats. The anti-RA effects were evaluated in CIA rats by arthritis score, hind paw volume and histopathology analysis. Pull-down assay was conducted to identify the potential targets of CAC extract from RAW264.7 macrophage lysates. Moreover, mechanism studies of CAC extract were performed by immunofluorescence assays, real-time PCR and Western blot.

Results: CAC extract was found to obviously down-regulate hind paw volume of CIA rats, with diminished inflammation response and damage. 177 targets were identified from CAC extract by MS-based pull-down assay. Bioinformatics analysis found that these targets were mainly enriched in macrophage activation and neutrophils extracellular traps (NETs). Additionally, we reported that CAC extract owned significant anti-inflammatory activity by regulating PI3K-Akt-mTOR signal pathway, and inhibited NETosis in response to PMA.

Conclusions: We clarified that CAC extract significantly attenuated RA by inactivating macrophage and reducing NETosis via a multi-targets regulation.

Citing Articles

The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis.

Chen J, Cao Y, Xiao J, Hong Y, Zhu Y Front Immunol. 2024; 15:1438272.

PMID: 39221253 PMC: 11361965. DOI: 10.3389/fimmu.2024.1438272.

References
1.
Xia T, Fu S, Yang R, Yang K, Lei W, Yang Y . Advances in the study of macrophage polarization in inflammatory immune skin diseases. J Inflamm (Lond). 2023; 20(1):33. PMC: 10568804. DOI: 10.1186/s12950-023-00360-z. View

2.
van der Woude D, van der Helm-van Mil A . Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018; 32(2):174-187. DOI: 10.1016/j.berh.2018.10.005. View

3.
Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G . Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2023; 13:1051082. PMC: 9817137. DOI: 10.3389/fimmu.2022.1051082. View

4.
Yao Y, Cai X, Ren F, Ye Y, Wang F, Zheng C . The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases. Front Immunol. 2021; 12:664871. PMC: 8044404. DOI: 10.3389/fimmu.2021.664871. View

5.
Alfaro-Lara R, Espinosa-Ortega H, Arce-Salinas C . Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in the treatment of rheumatoid arthritis. Reumatol Clin (Engl Ed). 2017; 15(3):133-139. DOI: 10.1016/j.reuma.2017.07.020. View